In 2011, Biomet’s fastest growing areas included sports medicine, while spine and trauma business lines slowed. All business lines except for spinal implants and trauma fixation grew in 2011.
The company also recently entered into strategic partnerships in the dental implant business line, which could contribute to its future revenue as well. In 2011, Biomet held more than 10 percent of the markets for dental implants and final abutments across the U.S., Europe, Asia-Pacific and Latin America, according to the report.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Devices:
OrhtoData Names Ric Navarro President and CEO
43 Orthopedic and Spine Devices Receive FDA 510(k) Clearance in October
Zimmer Acquires XtraFix External Fixation System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.